Complement Factor H Polymorphism and Age-Related Macular Degeneration
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Age-related macular degeneration (AMD) is a common, late-onset, and complex trait with multiple risk factors. Concentrating on a region harboring a locus for AMD on 1q25-31, the ARMD1 locus, we tested single-nucleotide polymorphisms for association with AMD in two independent case-control populations. Significant association ( P = 4.95 × 10 -10 ) was identified within the regulation of complement activation locus and was centered over a tyrosine-402 → histidine-402 protein polymorphism in the gene encoding complement factor H. Possession of at least one histidine at amino acid position 402 increased the risk of AMD 2.7-fold and may account for 50% of the attributable risk of AMD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A major AMD-associated SNP is the Y402H (tyrosine to histidine substitution at amino acid 402) variant of complement factor H (CFH) (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005).”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Edwards et al., 2005
In the citing paper
“These SNPs have been reported to be major genetic factors for developing AMD in Caucasians (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005; Tuo et al., 2006).”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Edwards et al., 2005
In the citing paper
“Complement activation playing a major role in AMD pathogenesis is yet another source of inflammation [107-110].”
From Risk mitigation of immunogenicity: a key to personalized retinal gene therapy (2021) · cites this paper as [108]
In the citing paper
“Polymorphisms in human complement regulatory factor H (CFH) predispose individuals to AMD [35, 46, 59]”
From Fecal microbiota transfer between young and aged mice reverses hallmarks of the aging gut, eye, and brain (2022) · cites this paper as [35]
In the citing paper
“Genes in the complement pathway4–11 and a region of chromosome 10 12,13 have now been implicated as the major genetic contributors to disease.”
From Seven new loci associated with age-related macular degeneration (2013) · cites this paper as [4]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Haploview: analysis and visualization of LD and haplotype maps
Barrett, J. C., Fry, B., Maller, J., & Daly, M. J. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bth457 · Cited by 14,525
Prevalence of Age-Related Macular Degeneration in the United States
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.564 · Cited by 2,736
Score Tests for Association between Traits and Haplotypes when Linkage Phase Is Ambiguous
Schaid, D. J., Rowland, C. M., Tines, D. E., Jacobson, R. M., & Poland, G. A. (2002) · The American Journal of Human Genetics · doi:10.1086/338688 · Cited by 1,783
The Five-year Incidence and Progression of Age-related Maculopathy
Klein, R., Klein, B. E. K., Jensen, S. C., & Meuer, S. M. (1997) · Ophthalmology · doi:10.1016/s0161-6420(97)30368-6 · Cited by 1,135
Mullins, R. F., Russell, S. R., Anderson, D. H., & Hageman, G. S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.835 · Cited by 937
The epidemiology of age-related macular degeneration
Klein, R., Peto, T., Bird, A., & Vannewkirk, M. R. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2003.11.069 · Cited by 932
Johnson, L. V., Leitner, W. P., Staples, M. K., & Anderson, D. H. (2001) · Experimental Eye Research · doi:10.1006/exer.2001.1094 · Cited by 621
Molecular Biology and Chemistry of the Alternative Pathway of Complement
Müller-Eberhard, H. J., & Schreiber, R. D. (1980) · Advances in Immunology · doi:10.1016/s0065-2776(08)60042-5 · Cited by 408
Seddon, J. M. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.6.785 · Cited by 398
Keenan, T. D., & Chew, E. Y. (2017) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2017.2210 · Cited by 377
Research works printed but not linked: 1
- M. H. Wener, P. R. Daum, G. M. McQuillan, J. Rheumatol.27, 2351 (2000).
Cited by
Items 601–700 of 1,021
Schaumberg, D. A., Christen, W. G., Kozlowski, P., Miller, D. T., Ridker, P. M., & Zee, R. Y. L. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-1456 · Cited by 74
Ross, R. J., Bojanowski, C. M., Wang, J. J., Chew, E. Y., Rochtchina, E., Ferris, F. L., Mitchell, P., Chan, C.-C., & Tuo, J. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-0999 · Cited by 75
Interconnection Between Brain and Retinal Neurodegenerations
Jindal, V. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8733-6 · Cited by 82
Csaky, K. G., Dugel, P. U., Pierce, A. J., Fries, M. A., Kelly, D. S., Danis, R. P., Wurzelmann, J. I., Xu, C., Hossain, M. S., & Trivedi, T. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.09.036 · Cited by 77
C-Reactive Protein and the Incidence of Macular Degeneration: Pooled Analysis of 5 Cohorts
Mitta, V. P., Christen, W. G., Glynn, R. J., Semba, R. D., Ridker, P. M., Rimm, E. B., Hankinson, S. E., & Schaumberg, D. A. (2013) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.2303 · Cited by 74
“8 The inflammatory hypothesis has been further strengthened by the discovery of a strong association between AMD and a common gene variant for complement factor H (CFH), 9,10,11,12 as well as variants in other complement pathway genes.”
BackgroundXu, Y.-L., Guan, N., Xu, J., Yang, X., Ma, K., Zhou, H., Zhang, F., Snellingen, T., Jiao, Y., Liu, X., et al. (2008) · PubMed Central · Cited by 92
Age-Related Macular Degeneration: Insights into Inflammatory Genes
Cascella, R., Ragazzo, M., Strafella, C., Missiroli, F., Borgiani, P., Angelucci, F., Marsella, L. T., Cusumano, A., Novelli, G., Ricci, F., et al. (2014) · Journal of Ophthalmology · doi:10.1155/2014/582842 · Cited by 72
Do Genomic Factors Play a Role in Diabetic Retinopathy?
Cabrera, A. P., Monickaraj, F., Rangasamy, S., Hobbs, S., McGuire, P. G., & Das, A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010216 · Cited by 78
Senabouth, A., Daniszewski, M., Lidgerwood, G. E., Liang, H. H., Hernández, D., Mirzaei, M., Keenan, S. N., Zhang, R., Han, X., Neavin, D. R., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31707-4 · Cited by 76
Pechtl, I. C., Kavanagh, D., Mcintosh, N., Harris, C. L., & Barlow, P. N. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.211839 · Cited by 70
Engelman, C. D., Meyers, K. J., Ziegler, J. T., Taylor, K. D., Palmer, N. D., Haffner, S. M., Fingerlin, T. E., Wagenknecht, L. E., Rotter, J. I., Bowden, D. W., et al. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.06.013 · Cited by 75
“For example, the complement factor H gene association with age-related macular degeneration (224 cases and 134 controls) [21], the NOS1AP gene association with cardiac repolarization (200 subjects) [22], the TNFSF15 gene conferring susceptibility to Crohn’s disease (94 subjects) [23], and the recent report of a region…”
ResultWiggs, J. L., Hauser, M. A., Abdrabou, W. S., Allingham, R. R., Budenz, D. L., DelBono, E. A., Friedman, D. S., Kang, J. H., Gaasterland, D., Gaasterland, T., et al. (2012) · Journal of Glaucoma · doi:10.1097/ijg.0b013e31824d4fd8 · Cited by 77
“5 (1-52) (4-21) (5-45) (9-21) N=2365 N=2282 N=844 N=350”
Scavenger Receptors for Oxidized Lipoprotein in Age-Related Macular Degeneration
Kamei, M., Yoneda, K., Kume, N., Suzuki, M., Itabe, H., Matsuda, K., Shimaoka, T., Minami, M., Yonehara, S., Kita, T., et al. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0699 · Cited by 78
Analysis of the Y402H Variant of the Complement Factor H Gene in Age-Related Macular Degeneration
Baird, P. N., Islam, F. M. A., Richardson, A. J., Cain, M., Hunt, N., & Guymer, R. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-1285 · Cited by 73
Friedrich, U., Myers, C. A., Fritsche, L. G., Milenkovic, A., Wolf, A., Corbo, J. C., & Weber, B. H. F. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr020 · Cited by 80
Loss of Complement Factor H impairs antioxidant capacity and energy metabolism of human RPE cells
Armento, A., Honisch, S., Panagiotakopoulou, V., Sonntag, I., Jacob, A., Bolz, S., Kilger, E., Deleidi, M., Clark, S., & Ueffing, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-67292-z · Cited by 73
Impaired monocyte cholesterol clearance initiates age-related retinal degeneration and vision loss
Ban, N., Lee, T. J., Sene, A., Choudhary, M., Lekwuwa, M., Dong, Z., Santeford, A., Lin, J. B., Malek, G., Ory, D. S., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.120824 · Cited by 74
Richards, A., Kavanagh, D., & Atkinson, J. P. (2007) · Advances in immunology · doi:10.1016/s0065-2776(07)96004-6 · Cited by 79
Kim, N. R., Kang, J., Kwon, O. W., Lee, S. J., Oh, J. H., & Chin, H. S. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1195 · Cited by 77
Age-related macular degeneration: a target for nanotechnology derived medicines
Birch, D. G., & Liang, F.-Q. (2007) · International Journal of Nanomedicine · doi:10.2147/nano.2007.2.1.65 · Cited by 78
Seddon, J. M., Gensler, G. R., & ROSNER, B. A. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2009.11.020 · Cited by 80
Gotoh, N., Yamada, R., Nakanishi, H., Saito, M., Iida, T., Matsuda, F., & Yoshimura, N. (2008) · Clinical and Experimental Ophthalmology · doi:10.1111/j.1442-9071.2008.01791.x · Cited by 75
Camelo, S. (2014) · Autoimmune Diseases · doi:10.1155/2014/532487 · Cited by 76
“First evidence that innate immunity was at play during AMD came from genetic studies showing that people with polymorphisms in the complement factor H (CfH) [12] [13] [14] [15] had an increased prevalence of AMD.”
BackgroundPlasma Protein Pentosidine and Carboxymethyllysine, Biomarkers for Age-related Macular Degeneration
Ni, J., Yuan, X., Gu, J., Yue, X., Gu, X., Nagaraj, R. H., & Crabb, J. W. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900127-mcp200 · Cited by 72
Triebwasser, M. P., Roberson, E. D. O., Yu, Y., Schramm, E. C., Wagner, E. K., Raychaudhuri, S., Seddon, J. M., & Atkinson, J. P. (2015) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.15-17432 · Cited by 70
Spotlight on reticular pseudodrusen
Rabiolo, A., Sacconi, R., Cicinelli, M. V., Querques, L., Bandello, F. M., & Querques, G. (2017) · Clinical ophthalmology · doi:10.2147/opth.s130165 · Cited by 74
UKA, J., TAMURA, H., KOBAYASHI, T., YAMANE, K., KAWAKAMI, H., MINAMOTO, A., & MISHIMA, H. K. (2006) · Retina · doi:10.1097/01.iae.0000244068.18520.3e · Cited by 72
Ethnic variation in AMD-associated complement factor H polymorphism p.Tyr402His
Grassi, M. A., Fingert, J. H., Scheetz, T. E., Roos, B. R., Ritch, R., West, S. K., Kawase, K., Shire, A. M., Mullins, R. F., & Stone, E. M. (2006) · Human Mutation · doi:10.1002/humu.20359 · Cited by 72
“E-mail: edwin-stone@uiowa.edu r 2006 WILEY-LISS, INC. demonstrated an association between AMD and the c.1204T4C, p.Tyr402His allelic variant in the Factor H (CFH; MIM] 134370) gene [Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005].”
BackgroundResultInfluentialVogt, S. D., Barnum, S. R., Curcio, C. A., & Read, R. W. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2006.04.002 · Cited by 71
Implications of genetic variation in the complement system in age-related macular degeneration
de Jong, S., Gagliardi, G., Garanto, A., de Breuk, A., Lechanteur, Y. T. E., Katti, S., van den Heuvel, L. P., Volokhina, E. B., & den Hollander, A. I. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100952 · Cited by 71
“Tyr402His (rs1061170) variant in the complement factor H (CFH) gene (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005).”
BackgroundKunchithapautham, K., & Rohrer, B. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.214593 · Cited by 71
Yang, S., Li, T., Jia, H., Gao, M., Li, Y., Wan, X., Huang, Z., Li, M., Zhai, Y., Li, X., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abj2177 · Cited by 78
Immune cells in the human choroid
Ezzat, M.-K., Hann, C. R., Vuk-Pavlovic, S., & Pulido, J. S. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.129742 · Cited by 68
Smailhodzic, D., Fleckenstein, M., Theelen, T., Boon, C. J. F., van Huet, R. A. C., van de Ven, J. P. H., den Hollander, A. I., Schmitz-Valckenberg, S., Hoyng, C. B., Weber, B. H. F., et al. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-7926 · Cited by 76
Cuticular drusen: Stars in the sky
Boon, C. J. F., van de Ven, J. P. H., Hoyng, C. B., den Hollander, A. I., & Klevering, B. J. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.08.003 · Cited by 75
Complement-Associated Deposits in the Human Retina
Seth, A., Cui, J., To, E., Kwee, M., & Matsubara, J. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1072 · Cited by 67
Marangoni, D., Falsini, B., Piccardi, M., Ambrosio, L., Minnella, A. M., Savastano, M. C., Bisti, S., Maccarone, R., Fadda, A., Mello, E., et al. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-228 · Cited by 73
“The Y402H polymorphism (rs1061170) in the complement factor H (CFH) gene [19-21], and the A69S polymorphism (rs10490924) in the Age-Related Maculopathy Susceptibility 2 (LOC387715/”
BackgroundGoldstein, O., Zangerl, B., Pearce‐Kelling, S., Sidjanin, D. J., Kijas, J., Felix, J. S., Acland, G. M., & Aguirre, G. K. (2006) · Genomics · doi:10.1016/j.ygeno.2006.05.013 · Cited by 71
“the CFH polymorphism in agerelated macular degeneration [21; 22; 23].”
BackgroundThe role of complement in ocular pathology
Bora, N. S., Jha, P., & Bora, P. S. (2008) · Seminars in Immunopathology · doi:10.1007/s00281-008-0110-y · Cited by 67
Differential turnover rates of monocyte-derived cells in varied ocular tissue microenvironments
Kezic, J., & McMenamin, P. G. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0308166 · Cited by 71
Progress in defining the molecular biology of age related macular degeneration
Lotery, A. J., & Trump, D. (2007) · Human Genetics · doi:10.1007/s00439-007-0406-3 · Cited by 76
Molins, B., Fuentes-Prior, P., Adán, A., Antón, R., Arostegui, J. I., Yagüe, J., & Dick, A. D. (2016) · Scientific Reports · doi:10.1038/srep22889 · Cited by 69
Liu, M. M., Chan, C.-C., & Tuo, J. (2012) · Human Genomics · doi:10.1186/1479-7364-6-13 · Cited by 69
“The Y402H polymorphism in CFH has been consistently demonstrated as a significant risk factor for AMD [13-15], and it has been estimated that the population attributable risk is between 47% and 69% [16].”
BackgroundComplement regulators in human disease: lessons from modern genetics
Liszewski, M. K., & Atkinson, J. P. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12338 · Cited by 78
Mori, K., Gehlbach, P. L., Kabasawa, S., Kawasaki, I., Oosaki, M., Iizuka, H., Katayama, S., Awata, T., & Yoneya, S. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-0426 · Cited by 70
“It has also been reported that the intronic single nucleotide polymorphisms (SNPs) of CFH were more associated with AMD than the Y402H variant.(7,8) Composite likelihood analysis using a high-resolution linkage disequilibrium (LD) map also indicated that there is at least one, and most likely several, variations other…”
BackgroundComplement Component 3 (C3) Haplotypes and Risk of Advanced Age-Related Macular Degeneration
Park, K. H., Fridley, B. L., Ryu, E., Tosakulwong, N., & Edwards, A. O. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-3231 · Cited by 69
Self-citationPhysiological Insights Gained from Gene Expression Analysis in Obesity and Diabetes
Keller, M. P., & Attie, A. D. (2010) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.012809.104747 · Cited by 69
“It is interesting to note that CFH, a gene associated with age-related macular degeneration in humans (36, 55, 77), is contained within a CNV that is well conserved across species (50) and was identified as a cis-eQTL in a study of human liver samples (125).”
The LOC387715 Polymorphism, Inflammatory Markers, Smoking, and Age-Related Macular Degeneration
Wang, J. J., Ross, R. J., Tuo, J., Burlutsky, G., Tan, A. G., Chan, C.-C., Favaloro, E. J., Williams, A., & Mitchell, P. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.05.038 · Cited by 69
Liu, X., Zhao, P., Tang, S., Lü, F., Hu, J., Lei, C., Yang, X. Q., Lin, Y., Ma, S., Yang, J., et al. (2010) · Retina · doi:10.1097/iae.0b013e3181cea676 · Cited by 73
Oxidative stress induced cellular signaling in RPE cells
Klettner, A. (2012) · Frontiers in Bioscience · doi:10.2741/275 · Cited by 67
“C-reactive proteins and heparin and thus is less inhibitory, has been shown to display a higher risk for developing AMD (193).”
BackgroundComplement activation as a biomarker for Alzheimer's disease
Aiyaz, M., Lupton, M. K., Proitsi, P., Powell, J. F., & Lovestone, S. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.07.023 · Cited by 78
Machalińska, A., Kawa, M. P., Marlicz, W. M., & Machaliński, B. (2011) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2011.02295.x · Cited by 78
“It has been documented that the presence of an unfavourable genetic Y402H variant is associated with a 2- to 2.5-fold increased risk of AMD in heterozygotes and a 5- to 5.5-fold increased risk in homozygotes (Edwards et al. 2005; Hageman et al. 2005; Haines et al. 2005; Klein et al. 2005).”
BackgroundInfluentialZhang, H., Morrison, M. A., DeWan, A. T., Adams, S. M., Andreoli, M. T., Huynh, N., Regan, M. R., Brown, A., Miller, J. W., Kim, I. K., et al. (2008) · BMC Medical Genetics · doi:10.1186/1471-2350-9-51 · Cited by 72
“We demonstrated that variants in the complement pathway genes CFH, CFHR2, CFHR4 and CFHR5 are significantly associated with AMD risk, however variants in these genes may not be independent factors in the pathophysiology of AMD due to the high LD throughout the 1q25-1q32 region [19-25].”
Topical Nonsteroidal Anti-Inflammatory Drugs for Macular Edema
Russo, A., Costagliola, C., Delcassi, L., Parmeggiani, F., Romano, M. R., dell’Omo, R., & Semeraro, F. (2013) · Mediators of Inflammation · doi:10.1155/2013/476525 · Cited by 73
“Thus, the collective evidence suggests that topical NSAIDsmay be used in place of topical corticosteroids after cataract surgery or, perhaps preferably, in addition to them; a number of clinical trials have reported a synergistic effect when NSAIDs and corticosteroids are administered together [49,…”
BackgroundChoriocapillaris Loss in Advanced Age-Related Macular Degeneration
Neto, C. A. M., Moult, E. M., Fujimoto, J. G., Waheed, N. K., & Ferrara, D. (2018) · Journal of Ophthalmology · doi:10.1155/2018/8125267 · Cited by 69
“Extensive experimental and genetic evidences suggest a major role of the alternative complement pathway in the development of AMD and GA [13].”
Role of the choroid in age-related macular degeneration: A current review
Ebrahimi, K., & Farazdaghi, M. (2019) · Journal of Ophthalmic and Vision Research · doi:10.4103/jovr.jovr_125_18 · Cited by 76
“[4,36‐40] In particular, significant association with AMD was seen in a tyrosine‐402→histidine‐402 polymorphism at the locus coding for complement factor H.[36] The complement cascade is a component of the innate immune system.”
BackgroundZipfel, P. F., Hallström, T., Hammerschmidt, S., & Skerka, C. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.11.015 · Cited by 68
Kaur, I., Katta, S., Hussain, A., Hussain, N., Mathai, A., Narayanan, R., Hussain, A., Reddy, R. K., Majji, A. B., Das, T., et al. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-0560 · Cited by 68
670-nm light treatment reduces complement propagation following retinal degeneration
Rutar, M., Natoli, R., Albarracin, R., Valter, K., & Provis, J. M. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-257 · Cited by 71
“These identified a significant association between the Y402H sequence variant in the regulatory gene complement factor H (CFH) with the incidence of AMD [22-25], as well as other susceptibility variants in complement pathway genes C2 [5,26], CFB [5,26], and the central component C3 [27-31].”
BackgroundHu, Y., Chen, Y., Lin, M., Lee, K., Mott, R. A., & Ma, J.-X. (2013) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.12-10281 · Cited by 53
Petrou, P. A., Cunningham, D., Shimel, K., Harrington, M., Hammel, K., Cukras, C. A., Ferris, F. L., Chew, E. Y., & Wong, W. T. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-15877 · Cited by 66
Genetics and molecular pathology of Stargardt-like macular degeneration
Vasireddy, V., Wong, P., & Ayyagari, R. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.01.001 · Cited by 68
“In addition, a number of gene variants associated with AMD, such as specific complement factor-H and B (CFH and CFB) alleles among others, have been identified that modify the risk for developing AMD (Edwards et al., 2005; Haines et al., 2005; Klein et al., 2005; Gold et al., 2006; Yates et al., 2007; Swaroop et al.,…”
BackgroundCruz‐Guilloty, F., Saeed, A. M., Duffort, S., Cano, M., Ebrahimi, K. B., Ballmick, A., Tan, Y., Wang, H., Laird, J. M., Salomon, R. G., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088201 · Cited by 75
Herbert, A. P., Makou, E., Chen, Z. A., Kerr, H., Richards, A., Rappsilber, J., & Barlow, P. N. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501388 · Cited by 68
Advances in Age-related Macular Degeneration Understanding and Therapy
Miller, J. W., Bagheri, S., & Vavvas, D. G. (2017) · touchREVIEWS in Ophthalmology · doi:10.17925/usor.2017.10.02.119 · Cited by 82
Shankar, A., Mitchell, P., Rochtchina, E., Tan, J., & Wang, J. J. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwk022 · Cited by 65
“Several research groups recently reported that genetic variation in a regulator of the alternative complement pathway (complement factor H gene) accounts for a significant attributable risk of AMD (34–41), perhaps around 50 percent (35, 36, 39).”
miRNAs as potential therapeutic targets for age-related macular degeneration
Wang, S., Koster, K. M., He, Y., & Zhou, Q. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.11.176 · Cited by 67
Genetics and genetic testing for age-related macular degeneration
Warwick, A., & Lotery, A. (2018) · Eye · doi:10.1038/eye.2017.245 · Cited by 67
Risk Factors Associated With Reticular Pseudodrusen Versus Large Soft Drusen
Boddu, S., Lee, M. D., Marsiglia, M., Marmor, M. F., Freund, K. B., & Smith, R. T. (2014) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2014.01.023 · Cited by 70
Freeman, S., Kozak, I., Cheng, L., Bartsch, D., Mojana, F., Nigam, N., Brar, M., Yuson, R. M. S., & Freeman, W. R. (2010) · Retina · doi:10.1097/iae.0b013e3181bd2f94 · Cited by 67
Plasma apolipoproteins and risk for age related maculopathy
Dashti, N., McGwin, G., Owsley, C., & Curcio, C. A. (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2006.093856 · Cited by 73
The complement system and age-related macular degeneration
Sivaprasad, S., & Chong, V. N. (2006) · Eye · doi:10.1038/sj.eye.6702176 · Cited by 74
A Perspective of AMD Through the Eyes of Immunology
Copland, D. A., Theodoropoulou, S., Liu, J., & Dick, A. D. (2018) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.18-23893 · Cited by 66
Shiose, S., Chen, Y., Okano, K., Roy, S., Kohno, H., Tang, J., Pearlman, E., Maeda, T., Palczewski, K., & Maeda, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.228551 · Cited by 65
Single-cell RNA sequencing in vision research: Insights into human retinal health and disease
Voigt, A. P., Mullin, N. K., Stone, E. M., Tucker, B. A., Scheetz, T. E., & Mullins, R. F. (2020) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100934 · Cited by 71
Macular and peripheral distribution of ICAM-1 in the human choriocapillaris and retina.
Mullins, R. F., Skeie, J. M., Malone, E. A., & Kuehn, M. H. (2006) · PubMed · Cited by 80
Age-Related Macular Degeneration: Clinical Findings, Histopathology and Imaging Techniques
Zarbin, M. A., Casaroli-Marano, R. P., & Rosenfeld, P. J. (2014) · Developments in ophthalmology · doi:10.1159/000358536 · Cited by 83
Lauer, N., Mihlan, M., Hartmann, A., Schlötzer-Schrehardt, U. M., Keilhauer, C. N., Scholl, H. P. N., Issa, P. C., Holz, F. G., Weber, B. H. F., Skerka, C., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002488 · Cited by 75
Robman, L. D., Baird, P. N., Dimitrov, P. N., Richardson, A. J., & Guymer, R. H. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.02.003 · Cited by 71
Seitsonen, S., Onkamo, P., Peng, G., Xiong, M., Tommila, P. V., Ranta, P., Holopainen, J. M., Moilanen, J., Palosaari, T., Kaarniranta, K., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003833 · Cited by 71
Genetic Determinants of Age-Related Macular Degeneration in Diverse Populations From the PAGE Study
Restrepo, N. A., Spencer, K. L., Goodloe, R., Garrett, T. A., Heiss, G., B kova, P., Jorgensen, N., Jensen, R. A., Matise, T. C., Hindorff, L. A., et al. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-14246 · Cited by 66
Fuse, N. (2010) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.221.1 · Cited by 80
Proteomic Analysis of the Aqueous Humor in Age-related Macular Degeneration (AMD) Patients
Kim, T., Kang, J. W., Ahn, J., Lee, E. K., Cho, K.-C., Han, B. N. R., Hong, N. Y., Park, J., & Kim, K. P. (2012) · Journal of Proteome Research · doi:10.1021/pr300080s · Cited by 67
Efficient selection of tagging single-nucleotide polymorphisms in multiple populations
Howie, B., Carlson, C. S., Rieder, M. J., & Nickerson, D. A. (2006) · Human Genetics · doi:10.1007/s00439-006-0182-5 · Cited by 68
Simonelli, F. (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2006.096487 · Cited by 66
To Release or Not to Release: Evaluating Information Leaks in Aggregate Human-Genome Data
Zhou, X., Peng, B., Li, Y. F., Chen, Y., Tang, H., & Wang, X. (2011) · Lecture notes in computer science · doi:10.1007/978-3-642-23822-2_33 · Cited by 82
The complement factor H‐related proteins
Medjeral‐Thomas, N., & Pickering, M. C. (2016) · Immunological Reviews · doi:10.1111/imr.12477 · Cited by 71
Chu-Tan, J. A., Rutar, M., Saxena, K., Aggio-Bruce, R., Essex, R. W., Valter, K., Jiao, H., Fernando, N., Wooff, Y., Madigan, M. C., et al. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-24623 · Cited by 65
Chapter 1 Common Genetic Variation and Human Disease
Orr, N., & Chanock, S. J. (2008) · Advances in genetics · doi:10.1016/s0065-2660(08)00601-9 · Cited by 79
Keenan, T. D. L., Pickford, C. E., Holley, R. J., Clark, S. J., Lin, W., Dowsey, A. W., Merry, C. L., Day, A. J., & Bishop, P. N. (2014) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.14-14126 · Cited by 65
Coughlin, B., Schnabolk, G., Joseph, K., Raikwar, H., Kunchithapautham, K., Johnson, K., Moore, K., Wang, Y., & Rohrer, B. (2016) · Scientific Reports · doi:10.1038/srep23794 · Cited by 65
A Blueprint for Advancing Genetics-Based Cancer Therapy
Sellers, W. R. (2011) · Cell · doi:10.1016/j.cell.2011.09.016 · Cited by 66
Cantsilieris, S., Nelson, B. J., Huddleston, J., Baker, C., Harshman, L., Penewit, K., Munson, K. M., Sorensen, M., Welch, A. E., Dang, V., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1717600115 · Cited by 63
Kawa, M. P., Machalińska, A., Rogińska, D., & Machaliński, B. (2014) · Journal of Immunology Research · doi:10.1155/2014/483960 · Cited by 73
“In more advanced stages of dry AMD, patients experience a loss in RPE and thinning of the photoreceptor layer in the macula, leading to retinal atrophy and surrounding tissue death in a process known as geographic atrophy (GA) [5].”
BackgroundAntibody therapies and their challenges in the treatment of age-related macular degeneration
Volz, C., & Pauly, D. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.02.020 · Cited by 73
Ding, J.-D., Kelly, U., Landowski, M., Toomey, C. B., Groelle, M., Miller, C., Smith, S. G., Klingeborn, M., Singhapricha, T., Jiang, H., et al. (2015) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.08.026 · Cited by 64
Polymorphisms of TREH, IL4R and CCDC26 genes associated with risk of glioma
Li, S., Jin, T., Zhang, J., Lou, H., Yang, B., Li, Y., Chen, C., & Zhang, Y. (2012) · Cancer Epidemiology · doi:10.1016/j.canep.2011.12.011 · Cited by 65
Francis, P. J., Zhang, H., DeWan, A. T., Hoh, J. J., & Klein, M. L. (2008) · PubMed Central · Cited by 73
Mechanism of Inflammation in Age-Related Macular Degeneration: An Up-to-Date on Genetic Landmarks
Parmeggiani, F., Sorrentino, F. S., Romano, M. R., Costagliola, C., Semeraro, F., Incorvaia, C., D’Angelo, S., Perri, P., Nadai, K. D., Roversi, E. B., et al. (2013) · Mediators of Inflammation · doi:10.1155/2013/435607 · Cited by 70
CD11c+ macrophages are proangiogenic and necessary for experimental choroidal neovascularization
Droho, S., Rajesh, A., Cuda, C. M., Perlman, H., & Lavine, J. A. (2023) · JCI Insight · doi:10.1172/jci.insight.168142 · Cited by 70
“JCI Insight 2023;8(7):e168142 https://doi.”
Metadata
- Authors
- Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A.
- Affiliations
- Boston University (US)
- Corresponding author
- Edwards, Albert O.
- Venue
- Science
- Published
- 2005-04-15
- Volume
- 308
- Issue
- 5720
- Pages
- 421-424
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W3145351529
- Cited by
- 2,449
- References
- 30
- Citations by year
- 2026: 24 · 2025: 41 · 2024: 51 · 2023: 48 · 2022: 78 · 2021: 105 · 2020: 73 · 2019: 52 · 2018: 81 · 2017: 65 · 2016: 89 · 2015: 120 · 2014: 141 · 2013: 146 · 2012: 166
- FWCI
- 195.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Eye Institute (EY014467, R01EY014467)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- age-related macular degeneration, complement factor H, CFH Y402H polymorphism, single nucleotide polymorphisms, genetic association, disease risk
- MeSH terms
- Aged, Alleles, Chromosomes, Human, Pair 1, Complement Activation, Female, Gene Frequency, Multigene Family, Genotype, Haplotypes, Histidine, Homozygote, Humans, Macular Degeneration, Male, Middle Aged, Risk Factors, Tyrosine, Genetic Variation, Linkage Disequilibrium, Case-Control Studies, Complement Factor H, Amino Acid Substitution, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.